WEBER CHRISTOPHE PIERRE (President and CEO) received a stock award from TAKEDA PHARMACEUTICAL CO LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 4/28/2026ACC: 0001395064-26-000140
DirectorOfficer· President and CEO
Since Mar 2026
+323.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
323.25K acquired
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+78.90K
Price / share
—
Trade value
—
% of position
8.4%
4/27/2026
935.30K→1.01M
American Depositary Shares
Direct
Shares
+165.37K
Price / share
—
Trade value
—
% of position
65.3%
4/27/2026
253.43K→418.80K
Total
Net shares
+244.27K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/27/2026 | A · Award | +78.90K | — | — | 8.4% | 935.30K | 1.01M |
| American Depositary Shares Direct | 4/27/2026 | A · Award | +165.37K | — | — | 65.3% | 253.43K | 418.80K |
| Total | +244.27K | $0.00 | ||||||
Derivative Transactions1
Tax Obligation Award
Direct
Converts to
Ordinary Shares
78.98K shares
Shares
+78.98K
Strike price
Held after
125.34K
Exercisable
—
4/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Tax Obligation Award Direct | Ordinary Shares78.98K shares | 4/27/2026 | A · Award | +78.98K | — | 125.34K |